FRI0221 Does seropositivity influence differentially drug discontinuation of biologic antirheumatic agents with non-anti-tnf mode of action?

A Finckh, D Courvoisier, J-E Gottenberg, X Mariette, J Morel, SA Bergstra, V Hernandez, C Codreanu, TK Kvien, MJ Santos, K Pavelka, M Hetland (+5 others)
2017 Poster Presentations   unpublished
doi:10.1136/annrheumdis-2017-eular.6006 fatcat:p7kx4a4bkberdo7aulr4lvtzm4